3B BlackBio Dx up 4.12% as AGM confirms ₹5/share dividend and adoption of FY26 accounts

According to the scrutinizer’s report dated September 29, 2026 and filed on September 30, 2026, shareholders of 3B BlackBio Dx Limited (formerly Kilpest India Limited) voted on five resolutions at the AGM held on September 29, 2026 at 11:30 A.M. (IST).

The record date for determining shareholders eligible to vote was September 22, 2026, with a total of 11,122 shareholders on record (page 8). All participation was via remote e‑voting and video conferencing; no shareholders were present in person or by proxy.

Key participation metrics from the voting results sheet (page 8–9):

• Total shares: 85,82,670
• Total votes polled across all categories: 57,35,751
• This represents 66.83% of outstanding shares being voted on each resolution.

Promoters and promoter group held 35,14,768 shares and polled 33,01,198 votes, a turnout of 93.92% on their holding. Public non‑institutional shareholders held 50,67,902 shares and polled 24,34,553 votes, or 48.04% of their holding (pages 9–13).

The clearest market‑sensitive item in the AGM agenda was the dividend proposal.

• Resolution 3 sought approval to declare a dividend of 50% i.e., ₹5/- per equity share, for the financial year 2025-26 (page 11).
• Total votes polled on this resolution were 57,35,751, or 66.83% of outstanding shares.
• Votes in favour: 57,35,750
• Votes against: 1
• That translates into 99.99% of votes polled backing the dividend, with virtually no opposition.

Resolutions to adopt the audited standalone and consolidated financial statements for the year ended March 31, 2026 (Resolutions 1 and 2) also passed with near‑unanimous support:

• For the standalone accounts (Resolution 1, page 9):

  • Total votes polled: 57,35,751 (66.83% of shares)
  • Votes in favour: 57,35,750
  • Votes against: 1
  • Favour percentage: 99.99%

• For the consolidated accounts (Resolution 2, page 10):

  • Total votes polled: 57,35,751 (66.83% of shares)
  • Votes in favour: 57,35,686
  • Votes against: 65
  • Favour percentage: 99.99%

The filing does not reproduce the FY26 revenue or profit figures themselves, nor does it break out margins; those were part of earlier financial results. However, the almost unanimous adoption of both standalone and consolidated accounts aligns with the positive FY26 performance that the market has been discussing.

Governance‑related resolutions also drew strong support, which investors often read as a sign of alignment between management and shareholders.

Resolution 4, a special resolution, sought to appoint a director in place of Mrs. Mithla Dubey (DIN: 03597415) who retires by rotation and, being eligible, offers herself for re‑appointment (page 12).

Because promoters were interested in this agenda item, the filing clearly flags that the Promoter and Promoter Group are interested in the agenda/resolution. Even so, the voting numbers show broad‑based backing:

• Total votes polled: 57,35,751 (66.83% of shares)
• Votes in favour: 55,51,686
• Votes against: 1,84,065
• Favour percentage: 96.79%
• Against percentage: 3.21%

While this resolution saw slightly more dissent than the others, a 96.79% approval rate still indicates very strong support for board continuity.

Resolution 5, to ratify remuneration of cost auditors (described as “To Ratify Remuneration of Cost Auditors” on page 13), passed with the same near‑unanimous pattern as the financial statements and dividend:

• Total votes polled: 57,35,751 (66.83% of shares)
• Votes in favour: 57,35,750
• Votes against: 1
• Favour percentage: 99.99%

The scrutinizer’s report itself is procedural, but the market reaction appears to be tied to what the voting pattern confirms:

1. Shareholder endorsement of cash returns: The ₹5 per share dividend for FY 2025-26 was not only proposed but backed by 99.99% of votes polled. That level of support reinforces the company’s shareholder‑return stance at a time when investors are already focused on its FY26 growth.

2. Validation of the FY26 numbers: Both standalone and consolidated financial statements for the year ended March 31, 2026 were adopted with 99.99% approval. This formal sign‑off comes after the company had earlier disclosed strong FY26 performance, which the broader market commentary has highlighted.

3. Governance continuity with limited pushback: The re‑appointment of Mrs. Mithla Dubey as director, with 96.79% of votes in favour, signals continuity in the boardroom. The modest 3.21% dissent is visible but not large enough to unsettle investors, especially with promoters voting and public non‑institutional shareholders still largely supportive.

4. Healthy participation: With 66.83% of the company’s 85,82,670 shares voting on each resolution, turnout was relatively high for an AGM conducted entirely via remote e‑voting and video conferencing (page 8). That level of engagement tends to reassure the market that decisions reflect a broad shareholder base.

The filing does not discuss forward guidance, order book, or margin trends, so the price reaction cannot be tied directly to any new financial projections. Instead, the 4.1% rise to Rs 1,690 appears to reflect investors marking the stock higher as the AGM process locked in a ₹5 dividend, confirmed the FY26 accounts, and showed strong backing for the existing governance structure.

For context, the scrutinizer’s report is narrow in scope. It:

• Does not restate revenue, profit after tax, or EPS for FY26.
• Does not provide margin data or segmental performance.
• Does not offer any commentary on FY27 outlook, capex, or strategy.

Those elements come from separate financial result filings and management commentary. The market’s positive read‑through on this AGM document is therefore more about confirmation and alignment than about fresh earnings information.

For investors tracking 3B BlackBio Dx, the key takeaway from this filing is that the company’s FY26 performance, dividend payout, and board composition have all cleared a significant shareholder test with overwhelming support, which in turn has coincided with the stock moving higher in the latest session.